The Rise of Pulsed Field Ablation: A Safer, Minimally Invasive Solution for Atrial Fibrillation and Cardiac Arrhythmias
18 oct. 2023 06h28 HE
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Areas, Source of Ablation, and Key Geographical Regions: Market Share...
Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation
04 oct. 2023 08h49 HE
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Electrophysiology Ablation Market Grows Strong, Aiming for US$ 7.9 Billion by 2033 | Persistence Market Research
28 sept. 2023 06h03 HE
|
Persistence Market Research
New York, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The electrophysiological ablation market is expected to generate US$ 3.1 billion in revenue globally in 2022 and grow at a CAGR of 8.8% to US$ 7.9...
Heart Centre Rigshospitalet Enhances Leadership in Patient Care with Adoption of Latest Robotic Technology
06 sept. 2023 08h56 HE
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals
24 août 2023 10h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig Introduces New Subscription Model for PURE EP™ Platform, Offering Quicker Access to Latest Features, Customizations
23 août 2023 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 23, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
Global Electrophysiology Market Size to Reach USD 18.01 Billion 2032 | Emergen Research
22 août 2023 10h00 HE
|
Emergen Research
Vancouver, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Anticipated to demonstrate a stable journey, the global electrophysiology market is poised to attain a value of USD 18.01 Billion, fostering a consistent...
BioSig's PURE EP™ Platform Debuts New Automated Features in First Patient Cases
22 août 2023 08h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 22, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications
25 juil. 2023 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, July 25, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...
BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals
20 juil. 2023 07h11 HE
|
BioSig Technologies, Inc.
Westport, CT, July 20, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company delivering unprecedented accuracy and precision to...